6/10
10:37 am
tech
Exosome Diagnostics and Therapeutics Market Surges, Anticipated to Hit USD 6,848 Million by 2032 | MarketsandMarkets™ [Yahoo! Finance]
Low
Report
Exosome Diagnostics and Therapeutics Market Surges, Anticipated to Hit USD 6,848 Million by 2032 | MarketsandMarkets™ [Yahoo! Finance]
6/5
06:39 am
tech
Exosomes Development and Manufacturing Market Worth USD 62.8 Billion to 2031- Best Report by InsightAce Analytic Pvt. Ltd. [Yahoo! Finance]
Medium
Report
Exosomes Development and Manufacturing Market Worth USD 62.8 Billion to 2031- Best Report by InsightAce Analytic Pvt. Ltd. [Yahoo! Finance]
6/3
09:24 am
tech
BioPharmaSpec Announces Major Investments in Mass Spectrometry and Related Instrumentation [Yahoo! Finance]
Low
Report
BioPharmaSpec Announces Major Investments in Mass Spectrometry and Related Instrumentation [Yahoo! Finance]
6/3
09:06 am
tech
BioPharmaSpec Announces Major Investments in Mass Spectrometry and Related Instrumentation [Financial Post (Toronto, Ontario, Canada)]
Low
Report
BioPharmaSpec Announces Major Investments in Mass Spectrometry and Related Instrumentation [Financial Post (Toronto, Ontario, Canada)]
5/31
07:00 am
tech
BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES
Low
Report
BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES
5/30
04:18 pm
tech
Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors [Yahoo! Finance]
Low
Report
Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors [Yahoo! Finance]
5/30
09:30 am
tech
Michael J. Fox Foundation Funds Projects to Speed Development of Quantitative Biomarkers for Parkinson's Disease [Yahoo! Finance]
Low
Report
Michael J. Fox Foundation Funds Projects to Speed Development of Quantitative Biomarkers for Parkinson's Disease [Yahoo! Finance]
5/30
07:24 am
tech
BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex™ SYSTEM AT THE ANNUAL ASMS CONFERENCE [Yahoo! Finance]
Low
Report
BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex™ SYSTEM AT THE ANNUAL ASMS CONFERENCE [Yahoo! Finance]
5/30
07:00 am
tech
BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex™ SYSTEM AT THE ANNUAL ASMS CONFERENCE
Low
Report
BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex™ SYSTEM AT THE ANNUAL ASMS CONFERENCE
5/29
07:24 am
tech
ScaleReady Announces $20 Million G-Rex® Grant Program for the Advancement of Cell and Gene Therapy (CGT) Development and Manufacturing [Yahoo! Finance]
Low
Report
ScaleReady Announces $20 Million G-Rex® Grant Program for the Advancement of Cell and Gene Therapy (CGT) Development and Manufacturing [Yahoo! Finance]
5/29
07:00 am
tech
ScaleReady Announces $20 Million G-Rex® Grant Program for the Advancement of Cell and Gene Therapy (CGT) Development and Manufacturing
Low
Report
ScaleReady Announces $20 Million G-Rex® Grant Program for the Advancement of Cell and Gene Therapy (CGT) Development and Manufacturing
5/23
10:36 am
tech
Multiple Headwinds Dragged Bio-Techne Corp. (TECH) in Q1 [Yahoo! Finance]
Low
Report
Multiple Headwinds Dragged Bio-Techne Corp. (TECH) in Q1 [Yahoo! Finance]
5/23
07:07 am
tech
BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE [Yahoo! Finance]
Medium
Report
BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE [Yahoo! Finance]
5/23
07:00 am
tech
BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE
Medium
Report
BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE
5/22
07:53 am
tech
Bio-Techne Co. (NASDAQ: TECH) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating. They now have a $85.00 price target on the stock.
Low
Report
Bio-Techne Co. (NASDAQ: TECH) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating. They now have a $85.00 price target on the stock.
5/22
07:11 am
tech
BIO-TECHNE HIGHLIGHTS RECENTLY ANNOUNCED TOP-LINE BIOMARKER DATA FROM PARTNER, REGULUS THERAPEUTICS, USING THE COMPANY'S PROPRIETARY TECHNOLOGY [Yahoo! Finance]
Low
Report
BIO-TECHNE HIGHLIGHTS RECENTLY ANNOUNCED TOP-LINE BIOMARKER DATA FROM PARTNER, REGULUS THERAPEUTICS, USING THE COMPANY'S PROPRIETARY TECHNOLOGY [Yahoo! Finance]
5/22
07:00 am
tech
BIO-TECHNE HIGHLIGHTS RECENTLY ANNOUNCED TOP-LINE BIOMARKER DATA FROM PARTNER, REGULUS THERAPEUTICS, USING THE COMPANY'S PROPRIETARY TECHNOLOGY
Low
Report
BIO-TECHNE HIGHLIGHTS RECENTLY ANNOUNCED TOP-LINE BIOMARKER DATA FROM PARTNER, REGULUS THERAPEUTICS, USING THE COMPANY'S PROPRIETARY TECHNOLOGY
5/21
03:23 pm
tech
Court Revokes Two Advanced Cell Diagnostics Patents, Dismisses Infringement Claims Against Molecular Instruments and Orders Advanced Cell Diagnostics to Make Payment of £1.35 Million to Molecular Instruments [Yahoo! Finance]
Low
Report
Court Revokes Two Advanced Cell Diagnostics Patents, Dismisses Infringement Claims Against Molecular Instruments and Orders Advanced Cell Diagnostics to Make Payment of £1.35 Million to Molecular Instruments [Yahoo! Finance]
5/21
03:00 pm
tech
Court Revokes Two Advanced Cell Diagnostics Patents, Dismisses Infringement Claims Against Molecular Instruments and Orders Advanced Cell Diagnostics to Make Payment of £1.35 Million to Molecular Instruments
Low
Report
Court Revokes Two Advanced Cell Diagnostics Patents, Dismisses Infringement Claims Against Molecular Instruments and Orders Advanced Cell Diagnostics to Make Payment of £1.35 Million to Molecular Instruments
5/16
11:18 am
tech
Expanding Horizons in Ferro Fluid Market: Comprehensive Analysis Forecasts Global Growth Through 2031 - Dual-Natured Ferro Fluids is on the Rise [Yahoo! Finance]
Low
Report
Expanding Horizons in Ferro Fluid Market: Comprehensive Analysis Forecasts Global Growth Through 2031 - Dual-Natured Ferro Fluids is on the Rise [Yahoo! Finance]
5/15
10:33 am
tech
Water Street Healthcare Partners Appoints Kevin Gould as Executive Advisor [Yahoo! Finance]
Low
Report
Water Street Healthcare Partners Appoints Kevin Gould as Executive Advisor [Yahoo! Finance]
5/14
05:05 am
tech
Bio-Techne Corporation (TECH) Declined on Weak Q4 Results [Yahoo! Finance]
Medium
Report
Bio-Techne Corporation (TECH) Declined on Weak Q4 Results [Yahoo! Finance]
5/9
06:44 am
tech
Bio-Techne Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Medium
Report
Bio-Techne Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
5/8
07:00 am
tech
BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024
Low
Report
BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024
5/7
07:16 am
tech
BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT) [Yahoo! Finance]
Low
Report
BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT) [Yahoo! Finance]